ACTINIUM PHARMACEUTICALS, INC. (ATNM) Capital expenditures 2016–2025
ACTINIUM PHARMACEUTICALS, INC. (ATNM) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$104,000FY2025 · since FY2016: $59,960 → $104,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $104,000 | +845.5% |
| FY2024 | $11,000 | -92.8% |
| FY2023 | $153,000 | -58.2% |
| FY2022 | $366,000 | +175.2% |
| FY2021 | $133,000 | -47.4% |
| FY2020 | $253,000 | +295.3% |
| FY2019 | $64,000 | -33.4% |
| FY2018 | $96,092 | +288.4% |
| FY2017 | $24,739 | -58.7% |
| FY2016 | $59,960 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice